Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer.
Qing ZhouJun ZhaoJianhua ChangHuijie WangYun FanKe WangGang WuWeiqi NianYuping SunMeili SunXiangcai WangHuaqiu ShiXiangqian ZhengSheng YaoMengmeng QinZhenwei ShenJason YangYi-Long WuPublished in: Cancer (2023)
NCT03037385.
Keyphrases